Co-founder and Chief Executive
Bob is a co-founder of BrightSpec and concentrates on recruiting, sales, operations, and corporate development. He brings to BrightSpec more than 15 years of executive experience in both start-up and Fortune 500 information services companies, along with a deep network of business relationships. Bob was instrumental in building ScholarOne, Inc., the #1 peer review system company for scientific, technical and medical (STM) publishers and in positioning the company for a successful exit. He previously spent several years in capital markets roles in New York, Chicago and London. BA, MA and MBA degrees from the University of Virginia.
Contact Bob: bob.lloyd(at)brightspec.com
Co-founder, Chief Operating Officer and Senior Software Architect
Dave concentrates on operational and technology platform development for BrightSpec, including algorithm development, information architecture, and mechanical engineering and design. Before co-founding BrightSpec, Dave spent nearly a decade in key roles at early stage companies in medical devices, distributed power generation, finance, and web applications development. Dave has extensive experience in virtual product design and optimization through computer-aided-engineering utilizing CAD, finite element analysis (FEA) and computational fluid dynamics (CFD). He has also served in experiment design and manufacturing roles for viscoelastic material characterizations used in vehicle crash worthiness design, precision manufacturing and metrology work in a clean room environment for assembly of metal-ceramic alloys. Dave was introduced to large data sets and numerical methods as part of the Computational Group at UVa’s Center for Applied Biomechanics. BS in Mechanical Engineering and Masters in Mechanical and Aerospace Engineering from the University of Virginia.
Contact Dave: dave.mcdaniel(at)brightspec.com
Brent Harris, PhD
Co-founder, Director of Applications Services and Applications Scientist
Brent is responsible for managing product application to industry challenges and brings extensive experience in instrument development and method development for MRR spectroscopy. His experience is in instrument design and building, sample preparation, data acquisition, processing and visualization. Before returning to graduate school in physical chemistry, he worked as a Quality Control Chemist at Sigma Aldrich. Leveraging expertise from both analytical and physical chemistry, he establishes the path from concept to product when engineering BrightSpec solutions for customer applications. Brent currently holds a PhD in Physical Chemistry from the University of Virginia, MA in Physical Chemistry from The University of Arizona and a BS in Chemistry from the University of Missouri.
Contact Brent: brent.harris(at)brightspec.com
Matt Muckle, MS
Co-founder, Software Developer and Applications Scientist
Matt is responsible for project management and for software development. His responsibilities include specifications management, component design, experiment design, and critically, the user interface development for Edgar, the BrightSpec software suite for instrument control, analysis, and spectral library management. He received his MS and BS in Chemistry from the University of Virginia, where his research work was in the design and implementation of microwave and millimeter wave instruments.
Contact Matt: matt.muckle(at)brightspec.com
Robin Pulliam, PhD
Co-founder, Director of Lab Operations and Applications Scientist
Robin is responsible for program management for the BrightSpec spectrometers, including instrument design, customer applications development and analytical services. Prior to BrightSpec, Robin was a Postdoctoral Fellow at the National Radio Astronomy Observatory in Charlottesville, VA where she assisted in the training of new ALMA (Atacama Large Millimeter/submillimeter Array) users, tested ALMA Cycle 0 and 1 software, and managed Splatalogue, a transition resolved compilation of freely available spectral line catalogs for astronomers and molecular spectroscopists. Robin received her PhD from the University of Arizona in Physical Chemistry with an emphasis in the study of Astrochemistry. At UofA, Robin gained valuable experience in the laboratory with millimeter and microwave components where she studied rotational spectroscopy of highly transient radical metal species. She also has extensive experience in single dish radio observations and during her time in graduate school took part in testing the new ALMA Band 3 and Band 6 type receivers at the Arizona Radio Observatory. She received her BS in Chemistry and Physics from Radford University.
Contact Robin: robin.pulliam(at)brightspec.com
Justin Neill, PhD
Co-founder and Chief Technology Officer
Justin brings substantial experience in applied spectroscopy to BrightSpec. He completed his PhD in the Pate Lab at the University of Virginia in 2011 and spent the following 2 years as a postdoctoral researcher at University of Michigan-Ann Arbor analyzing interstellar spectra from the Hershel Space Telescope. As a co-inventor on one of the BrightSpec instrument patents, Justin has an in-depth knowledge of product design for both microwave and millimeter wave spectrometers and how to deploy them to solve new analytical challenges.
Contact Justin: justin.neill(at)brightspec.com
Director of Instrument Production
Roger is responsible for engineering and building BrightSpec microwave instruments, including design alternatives, implementation and debugging of new mechanical, chemical and electrical systems. Prior to joining BrightSpec, Roger held Senior Scientist roles at the University of Virginia in the Department of Mechanical and Aerospace Engineering, and was a Product Engineer at General Dynamics/Veridian Advanced Information Systems. At Avir Sensors, Roger coordinated R&D, management, and contract manufacturing partners to design, produce, and test a novel open-path infrared gas detection product for life-safety applications. State University of New York at Alfred, AAS, Chemical Technology and University of Minnesota, Aerosol and Particle Measurement.
Contact Roger: roger.reynolds(at)brightspec.com
Caitlin’s responsibilities encompass many aspects of our business, including financial, budget and purchasing management. She handles all client billings, website maintenance, operations and office management duties. With her versatile skills and willingness to learn she works hard to insure that operations are running smoothly. B.Sc. in Finance, University of North Carolina at Wilmington.
Contact Caitlin: caitlin.prysock(at)brightspec.com
Shelby is responsible for running chemical analyses using the BrightSpec MRR products. We works to optimize and refine existing spectrometer designs mechanical design, usability, method development, robustness and accuracy of analysis. B.Sc. in Chemistry, University of Virginia.
Contact Shelby: shelby.fields(at)brightspec.com
B. Frank Gupton, Ph.D.
Scientific Advisory Board
Chair and Professor, Department of Chemical and Life Science Engineering
Virginia Commonwealth University
Frank Gupton has more than 30 years of senior executive experience in pharmaceutical science and process development. At VCU, his research group is focused on the development and application of new technologies that will streamline organic synthesis through process intensification. The goal of process intensification is to increase the overall efficiency and selectivity of chemical reactions by using novel chemistry and/ or running reactions under more extreme process conditions (temperature and pressure). They are interested in applying these principals towards the development of new catalyst systems that can be used in concert with continuous chemical processing (flow reactor technology) to streamline the synthesis of pharmaceutical active ingredients (API’s).
Prior to taking his current role at VCU, Frank was Executive Director, Process Development for Boehringer Ingelheim Chemicals, Inc. and previously held senior management roles at Hoechst Celanese. In his current role at VCU, Frank collaborates with researchers at the University of Washington, Florida State University and the Massachusetts Institute of Technology on the Medicine for All Initiative. His work is funded by a $4.4mm grant in January 2015 from the Bill & Melinda Gates Foundation, in partnership with the Clinton Health Access Initiative. The grant supports the Gupton Group’s work to reduce the manufacturing cost of nevirapine, a first-line therapy for the treatment of AIDS. In June, the initiative was awarded a further $5mm grant to find ways to drive down the costs of manufacturing the AIDS drugs tenofovir and darunavir. Darunavir is known as a second-line therapy and is often prescribed once a patient develops a resistance to first-line therapies.
Robin A. Felder PhD
Dr. Robin Felder is a Professor of Pathology and Associate Director of Laboratory Medicine at the University of Virginia-UVA, and is Chair of Medical Automation.org. Dr. Felder received his PhD in Biochemistry from Georgetown University. He has published over 300 papers, reviews, and chapters, and co-edited 3 textbooks on medical automation. He has been awarded 27 patents and has founded 9 biotech companies, including 2 non-profit organizations including the Association for Laboratory Automation (SLAS) (and its journal JALA) as well as Medical Automation.org. He has received numerous awards including the Engelberger Robotics Award, UVA’s Innovator of the Year Award, and the Annual Research Awards from the American Association for Clinical Chemistry (AACC), and National Academy for Clinical Biochemistry (NACB).